Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Supplementary Figure S2 from Olaparib Plus Durvalumab, with or Without Bevacizumab, As Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study

Yvette Drew, Jae-Weon Kim,Richard T. Penson,David M. O'Malley,Christine Parkinson,Patricia Roxburgh,Ruth Plummer,Seock-Ah Im,Martina Imbimbo,Michelle Ferguson,Ora Rosengarten,Neeltje Steeghs,Min Hwan Kim,Einav Gal-Yam,Daliah Tsoref, Jae-Hoon Kim,Benoit You,Maja De Jonge,Roy Lalisang,Eelke Gort,Sara Bastian,Kassondra Meyer,Laura Feeney,Nigel Baker,Mei-Lin Ah-See,Susan M. Domchek,Susana Banerjee

openalex（2024）

Cited 0|Views1
Key words
Platinum-Sensitive Ovarian Cancer,Olaparib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined